Pharmacological characterization of nicotine-induced seizures in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1284-1291

  Damaj, M Imad ^a   Glassco, W ^a   Dukat, M ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; DIHYDRO BETA ERYTHROIDINE; GLUTAMIC ACID; HEXAMETHONIUM; MECAMYLAMINE; METHYLLYCACONITINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; DRUG EFFECT; DRUG POTENCY; EPILEPTOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTICONVULSANTS; BRAIN CHEMISTRY; CALCIUM SIGNALING; DIHYDROPYRIDINES; GLUTAMIC ACID; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NITRIC OXIDE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SEIZURES;

EID: 0032732961     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Aceto MD (1975) The antinicotinic effects of drugs with clinically useful sedative-antianxiety properties. Pharmacology 13:458-464.
2. Aceto MD, Martin BR, Uwaydah IM, May EL, Harris LS, Izazola-Conde C, Dewey WL and Vincek WC (1979) Optically pure (+)-nicotine from (±)-nicotine and biological comparisons with (-)-nicotine. J Med Chem 22:174-177.
3. Acheson RM, Ferris MJ and Sinclair NM (1980) Transformations involving the pyrrolidine ring of nicotine. J Chem Soc 2:679-585.
4. Barrass B, Blackburn J, Brimblecombe R and Rich P (1969) Modification of nicotine toxicity by pretreatment with different drugs. Biochem Pharmacol 18:2145-2152.
5. Bertrand D, Ballivet M and Rungger D (1990) Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes. Neurobiology 87:1993-1997.
6. Briggs CA and McKenna DG (1996) Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology 35:407-414.
7. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptors antagoniste. Cire Res 72:387-395.
8. 6" type. Neuropharmocology 22:347-351.
9. Chavez-Noriega LE, Crona JH, Washburn MS, Urrita A, Elliott KJ and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotonic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4, and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
10. Connolly J, Boulter J and Heinemann SF (1992) Alpha4-2beta/2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br J Pharmacol 105:657-666.
11. Conti-Tronconi B, McLane K, Raftery M, Grando S and Protti M (1994) The nicotinic acetylcholine receptor: Structure and autoimmune pathology. Crit Rev Biochem Mol Biol 29:69-123.
12. Couturier S, Erkman L, Valera S, Rungger D, Bertrand S, Boulter J, Ballivet M and Bertrand D (1990) Alpha5, alpha3, and non-alpha3: Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits. J Biol Chem 265:17560-17567.
13. Damaj I, Welch S and Martin B (1993) Involvement of calcium and L-type channels in nicotine-induced antinociception. J Pharmacol Exp Ther 266:1330-1338.
14. Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA and Martin BR (1998) Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 284:1058-1065.
15. Damaj MI and Martin BR (1993) Calcium agonists and antagonists of the dihydropyridine type: Effect on nicotine-induced antinociception and hypomotility. Drug Alcohol Depend 32:73-79.
16. Damaj MI, Welch SP and Martin BR (1995) In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist in mice. Psychopharmacology 117: 67-73.
17. Dixit KS, Dhasmana KM, Saxena RC and Kohli RP (1971) Antagonism of intracerebrally induced nicotinic convulsions in mice: A method for measuring the central antinicotinic activity of CNS acting agents. Psychopharmacology 19:67-72.
18. Dukat M, Fiedler W, Dumas D, Damaj MI, Martin BR, Rosecrans JA, James JR and Glennon RA (1996) Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation. Eur J Med Chem 31:875-888.
19. Fedele E, Varnier G, Ansaldo MA and Raiteri M (1998) Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol 126:1042-1048.
20. Floris V, Morocutti C and Ayala GF (1964) Effects of nicotine on cortical, thalamic and hippocampal electrical activity in rabbits. J Neuropsychiatry 5:247-251.
21. Glassco W, May EL, Weaver V, Damaj MI, Rosecrans J and Martin BR (1994) Pharmacological investigation of N-substituted derivatives of (±)-norisonicotine. Med Chem Res 4:474-482.
22. Glennon RA, Maarouf A, Fahmy S, Martin B, Fan F, Yousif M, Shafik RM and Malgorzata D (1993) Structure-affinity relationships of simple nicotine analogs. Med Chem Res 2:546-551.
23. Hardick DJ, Blagbrough IS, Cooper G, Potter BVL, Critchley T and Wonnacott S (1996) Nudicauline and elatine as potent norditerpenoid liganda at rat neuronal α-bungarotoxin binding sites: Importance of the 2-(methylsuccinimido) benzoyl moiety for neuronal nicotinic acetylcholine receptor binding. J Med Chem 39: 4860-4866.
24. Hitchott PK, Zharkovsky A and File SE (1992) Concurrent treatment with verapamil prevents diazepam withdrawal-induced anxiety, in the absence of altered calcium flux in cortical synaptosomes. Neuropharmacology 31:55-60.
25. Litchfield ST and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
26. Little HJ (1991) The role of neuronal calcium channels in dependence on ethanol and other sedatives/hypnotics. Pharmacol Ther 50:347-365.
27. McGeehee D, Heath M, Gelber S, Devay P and Role L (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science (Wash DC) 269:1692-1696.
28. McLane KE, Wu X, Lindstrom JM and Conti-Tronconi BM (1992) Epitope mapping of polyclonal and monoclonal antibodies against two α-bungarotoxin-binding alpha subunits from neuronal nicotinic receptors. J Neuroimmunol 38:115-128.
29. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44:814-23.
30. Meyer EM, Tay ET, Papke RL, Meyers C, Huang G-L and de Fiebre CM (1997) 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768:49-56.
31. Miller RJ (1987) Multiple calcium channels and neuronal functions. Science (Wash DC) 235:46-52.
32. Miner LL and Collins AC (1988) The effect of chronic nicotine treatment on nicotine-induced seizures. Psychopharmacology 95:52-55.
33. Miner LL and Collins AC (1989) Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 33:469-475.
34. Miner LL, Marks MJ and Collins AC (1985) Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sci 37:75-83.
35. Mulle C, Choquet D, Korn H and Changeux J-P (1992) Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation. Neuron 8:135-143.
36. Pedigo NW, Dewey WL and Harris LS (1975) Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther 193:845-852.
37. Perez de la Mora M, Mendez-Franco J, Salceda R, Aguirre JA and Fuxe K (1991) Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain. Acta Physiol Scand 141:241-250.
38. Shoaib M, Benwell M, Akbar M, Stolerman I and Balfour D (1994) Behavioural and neurochemical adaptions to nicotine in rats: Influence of NMDA antagonists. Sr J Pharmacol 110:1073-1080.
39. Stitzel JA, Blanchette JM and Collins AC (1998) Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the α5 and α7 nicotinic receptor subunit genes. J Pharmacol Exp Ther 284:1104-1111.
40. Stumpf C and Gogolak G (1967) Actions of nicotine in the limbic system. Ann NY Acad Sci 142:143-158.
41. Synder SH and Bredt DS (1991) Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 12:125-128.
42. Turek J, Kang C, Campbell J, Arneric S and Sullivan J (1995) A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61:113-118.
43. Ward J, Cockcroft V, Lunt G, Smillie F and Wonnacott S (1990) Methyllycaconitine: A selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett 270:45-48.